Exacerbation of the inflammatory response toMycobacterium tuberculosisafter antiretroviral therapy
- 1 November 1998
- journal article
- case report
- Published by AMPCo in The Medical Journal of Australia
- Vol. 169 (9) , 473-474
- https://doi.org/10.5694/j.1326-5377.1998.tb123372.x
Abstract
A patient with HIV infection was successfully treated for pulmonary tuberculosis, but pulmonary inflammation and lymphadenitis worsened dramatically after subsequent combination antiretroviral therapy. As this relapse coincided with development of a strong delayed‐type hypersensitivity response to tuberculin and improved after treatment with the anti‐inflammatory agent oxpentifylline, it was probably caused by restoration of pathogen‐specific cellular immunity.Keywords
This publication has 8 references indexed in Scilit:
- Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 diseaseThe Lancet, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Pentoxifylline Therapy in Human Immunodeficiency Virus--Seropositive Persons with Tuberculosis: A Randomized, Controlled TrialThe Journal of Infectious Diseases, 1996
- Cavitary Pulmonary Lesions in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudineAIDS, 1994
- Pathogenesis of human immunodeficiency virus infection.Microbiological Reviews, 1993
- Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patientsAIDS, 1992
- Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosisImmunology Today, 1991